NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-
testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit …

The immune system has a substantial effect on colorectal cancer (CRC) progression.
Additionally, the response to immunotherapeutics and conventional treatment options (eg …

Human leukocyte antigen G (HLA-G), known as a central protein in providing immune
tolerance to the fetus in pregnant women, is also studied for a possible role in tumor …

Understanding the contribution of the host's genetic background to cancer immunity may
lead to improved stratification for immunotherapy and to the identification of novel …

Background An immune active cancer phenotype typified by a T helper 1 (Th-1) immune
response has been associated with increased responsiveness to immunotherapy and …

Objective Biological insights into the stepwise development and progression of colorectal
cancer (CRC) are imperative to develop tailored approaches for early detection and optimal …

Background Large immunogenomic analyses have demonstrated the prognostic role of the
functional orientation of the tumor microenvironment in adult solid tumors, this variable has …

According to publicly available transcriptome datasets, the abundance of Annexin A3
(ANXA3) is robustly increased during the course of sepsis; however, no studies have …

With the advent of checkpoint inhibition, immunotherapy has revolutionized the clinical
management of several cancers, but has demonstrated limited efficacy in mammary …

Motivation We previously described the construction and characterization of fixed reusable
blood transcriptional module repertoires. More recently we released a third iteration …